Thamm, Douglas H.

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., et al. (2010) · Proceedings of the National Academy of Sciences

T-cell and B-cell ImmunologyLymphoma Diagnosis and Treatment

Cited by 1,561

Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology

LeBlanc, A. K., Breen, M., Choyke, P., Dewhirst, M., Fan, T. M., Gustafson, D. L., Helman, L. J., Kastan, M. B., Knapp, D. W., Levin, W. J., et al. (2016) · Science Translational Medicine

Veterinary Oncology ResearchScience, Research, and Medicine

Cited by 147

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Regan, D. P., Chow, L., Das, S., Haines, L., Palmer, E., Kurihara, J. N., Coy, J. W., Mathias, A., Thamm, D. H., Gustafson, D. L., et al. (2022) · Clinical Cancer Research

Veterinary Oncology ResearchSarcoma Diagnosis and Treatment

Cited by 92

The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine

Fowles, J. S., Dailey, D. D., Gustafson, D. L., Thamm, D. H., & Duval, D. L. (2017) · Veterinary and Comparative Oncology

Veterinary Oncology ResearchCancer Cells and Metastasis

Cited by 49

Canine Cancer: Strategies in Experimental Therapeutics

Thamm, D. H. (2019) · Frontiers in Oncology

Veterinary Oncology ResearchHuman-Animal Interaction Studies

Cited by 38

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

Brady, R. V., & Thamm, D. H. (2023) · Frontiers in Immunology

Immune cells in cancerVeterinary Oncology Research

Cited by 35